Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 44 percent decrease over losses of $(0.25) per share from the same period last year.
EOS Network Foundation CEO Launches Game-Changing Initiatives To Propel Bull Run
The EOS Network Foundation, under the leadership of CEO Yves La Rose, is actively preparing for what they believe will be the next significant surge in the blockchain sector.
